Coya Therapeutics, Inc. (COYA)
NASDAQ·Healthcare·Biotechnology
$3.93
-1.75%
Mkt Cap $80.42M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
Implied Upside
+345.3%
Consensus $17.50 vs current $3.93
NASDAQ·Healthcare·Biotechnology
$3.93
-1.75%
Mkt Cap $80.42M
No recent rating data.
Price Target (2 analysts)
$17.50
Range $17.00 – $18.00
+345.3%
Consensus $17.50 vs current $3.93